FI904025A0 - Halogenalkylfenylalkoholer. - Google Patents

Halogenalkylfenylalkoholer.

Info

Publication number
FI904025A0
FI904025A0 FI904025A FI904025A FI904025A0 FI 904025 A0 FI904025 A0 FI 904025A0 FI 904025 A FI904025 A FI 904025A FI 904025 A FI904025 A FI 904025A FI 904025 A0 FI904025 A0 FI 904025A0
Authority
FI
Finland
Prior art keywords
halogenalkylfenylalkoholer
haloalkylphenyl
hydrates
therapeutics
ketones
Prior art date
Application number
FI904025A
Other languages
English (en)
Finnish (fi)
Inventor
Sylvain Cottens
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI904025A0 publication Critical patent/FI904025A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI904025A 1989-08-16 1990-08-14 Halogenalkylfenylalkoholer. FI904025A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3927049A DE3927049A1 (de) 1989-08-16 1989-08-16 Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
FI904025A0 true FI904025A0 (fi) 1990-08-14

Family

ID=6387229

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904025A FI904025A0 (fi) 1989-08-16 1990-08-14 Halogenalkylfenylalkoholer.

Country Status (18)

Country Link
US (1) US5166181A (cs)
EP (1) EP0413667B1 (cs)
JP (1) JPH03101643A (cs)
KR (1) KR910004539A (cs)
AT (1) ATE95166T1 (cs)
AU (1) AU632844B2 (cs)
CA (1) CA2023233A1 (cs)
CZ (1) CZ411391A3 (cs)
DE (2) DE3927049A1 (cs)
DK (1) DK0413667T3 (cs)
ES (1) ES2060127T3 (cs)
FI (1) FI904025A0 (cs)
HU (1) HUT58686A (cs)
IE (1) IE902938A1 (cs)
IL (1) IL95370A0 (cs)
NZ (1) NZ234902A (cs)
PT (1) PT94997A (cs)
ZA (1) ZA906506B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
CA2250068A1 (en) * 1996-03-19 1997-09-25 G.D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
IT1304904B1 (it) 1998-09-11 2001-04-05 Eisai Co Ltd Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche
JP4639042B2 (ja) * 2003-09-29 2011-02-23 富士フイルムファインケミカルズ株式会社 ハロゲン−リチウム交換反応を用いる有機化合物の製造法
CN101100455B (zh) 2006-07-05 2015-08-05 天津合美医药科技有限公司 具有镇痛作用的5,9-甲撑环辛并(b)吡啶-2(1H)酮衍生物及其制备和应用
WO2011100373A1 (en) 2010-02-09 2011-08-18 The Johns Hopkins University Methods and compositions for improving cognitive function
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP3827820A1 (en) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam for improving cognitive function
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ， インコーポレイテッド 認知機能を改善するための方法および組成物
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2840617A (en) * 1954-10-25 1958-06-24 Shell Dev New polyols, their preparation and derivatives
DE1934130A1 (de) * 1968-07-26 1970-01-29 Boehringer Sohn Ingelheim Acylphenylalkylamine und ihre Herstellung
US3996279A (en) * 1973-01-02 1976-12-07 Gerot-Pharmazeutika Dr. Walter Otto K.G. Novel 2-amino methyl-4,6-dihalogenphenol derivatives and methods for the preparation thereof
US4211794A (en) * 1979-01-08 1980-07-08 Pfizer Inc. N,N-Disubstituted aminomethylphenylethanolamines
JPS62252737A (ja) * 1986-04-01 1987-11-04 Japan Tobacco Inc アルデヒドまたはケトンのアルコールへの還元方法
EP0432719A1 (en) * 1989-12-14 1991-06-19 Hoechst-Roussel Pharmaceuticals Incorporated Alkylamino- and alkylaminoalkyl diarylketones, a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
PT94997A (pt) 1991-04-18
EP0413667A1 (de) 1991-02-20
KR910004539A (ko) 1991-03-28
ES2060127T3 (es) 1994-11-16
CA2023233A1 (en) 1991-02-17
ZA906506B (en) 1992-04-29
DE3927049A1 (de) 1991-02-21
EP0413667B1 (de) 1993-09-29
DK0413667T3 (da) 1993-11-08
ATE95166T1 (de) 1993-10-15
JPH03101643A (ja) 1991-04-26
CZ411391A3 (en) 1994-01-19
HU904868D0 (en) 1991-01-28
US5166181A (en) 1992-11-24
DE59002905D1 (de) 1993-11-04
HUT58686A (en) 1992-03-30
IL95370A0 (en) 1991-06-30
NZ234902A (en) 1993-01-27
AU632844B2 (en) 1993-01-14
IE902938A1 (en) 1991-02-27
AU6101590A (en) 1991-02-21

Similar Documents

Publication Publication Date Title
ATE69817T1 (de) Tetraoxodiazabicyclo-(3,3,1)-nonane.
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
FI904025A0 (fi) Halogenalkylfenylalkoholer.
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
IT1113390B (it) Copolimero ad innesto utile nella elettrodeposizione
ATE137970T1 (de) Als männliches kontrazeptikum verwendbare zusammensetzungen
DK313587D0 (da) Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
ES2021634B3 (es) Procedimiento para la eliminacion del eter de dimetilo en cloruro de metilo.
IT1141392B (it) Procedimento di trasformazione dell'idrargillite in boemite
IT1186694B (it) Ftalocianine,loro preparazione e loro impiego come coloranti
ES517874A0 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
ATE111099T1 (de) Ergolinderivate.
IL57838A0 (en) N-cyclohexyl-n-methoxyacetamide,its preparation and its use in the preparation of o-methyl-n-cyclohexyl-2,5-dimethylfuran-3-hydroxamic acid
GB2003855A (en) Triphenylbut-1-ene derivative
AR218780A1 (es) Mejoras en sillas ortopedicas
IT7827080A0 (it) Composizione ad uso cosmetico erelativo procedimento di preparazione.
IT1120693B (it) Busto ortopedico
NO911706L (no) Anvendelse av utvalgte etere av mono-hydroksyalkoholer i boreslam
IT1102588B (it) Composizione antisettica e antidolo rifica, particolarmente per uso otoiatrico
FI862995A (fi) Fenyl-(4-hexametyleniminopropyl) -keton.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: SANDOZ AG